Related Experiment Video
Updated: Jun 26, 2026
05:15
Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia
Published on: June 21, 2024
Synopsis report from the pilot USA Kernicterus Registry
1Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital, Stanford, CA, USA. bhutani@stanford.edu
Summary
System failures in newborn care cause most kernicterus cases. New strategies and guidelines are crucial for preventing severe newborn jaundice and kernicterus through better parent-clinician partnerships.
Area of Science:
- Neonatal Health
- Public Health
- Healthcare Systems
Background:
- Breakdowns in safe newborn healthcare delivery are the primary cause of kernicterus in the US.
- Traditional methods fail to track severe hyperbilirubinemia and kernicterus incidence, missing a recent surge.
- Investigative strategies must identify better surrogates for kernicterus and address limitations in tracking adverse neonatal events.
Purpose of the Study:
- To analyze root causes of kernicterus in infants over the past two decades.
- To identify clinical and health-service barriers faced by families seeking care for newborns.
- To inform the development of improved guidelines for managing newborn jaundice.
Main Methods:
- Root cause analysis of a cohort of infants with kernicterus.
- Review of clinical and health-service delivery patterns.
- Analysis of barriers in healthcare navigation for newborns.
Main Results:
- Identified significant clinical and health-service barriers hindering preventive care for newborn jaundice.
- Highlighted unawareness among clinicians, organizations, parents, and payors regarding care patterns obstructing prevention.
- Recommendations led to new clinical and national guidelines for evidence-based newborn jaundice management.
Conclusions:
- Systemic improvements and evidence-based guidelines are essential for safer newborn jaundice management.
- Clinician and family toolkits have been developed to aid guideline implementation.
- Informed partnerships between parents and clinicians are key to preventing severe hyperbilirubinemia and kernicterus.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...